SCHEMBL6162081

SCHEMBL6162081

O=[N+]([O-])c1ccc(Oc2ccc(CCl)cc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSPB1 P04792 1/20 0.59
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
MAPK1 P28482 2/20 0.51
NPC1 O15118 1/20 0.51
MAPT P10636 1/20 0.51
RAB9A P51151 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
MYOC Q99972 1/20 0.51
ALDH1A1 P00352 2/20 0.50
IDO1 P14902 2/20 0.50
LOXL2 Q9Y4K0 1/20 0.50
SRD5A2 P31213 1/20 0.50
TSHR P16473 3/20 0.49
CYP3A4 P08684 1/20 0.49
HSD17B10 Q99714 1/20 0.49
LTA4H P09960 1/20 0.48
PTGS1 P23219 1/20 0.48
PTGS2 P35354 1/20 0.48
MGLL Q99685 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL99564 0.88 LOXL2 (0.61) MEN1KMT2AALDH1A1IDO1LOXL2
SCHEMBL2000238 0.85 HSPB1 (0.63) HSPB1MEN1KMT2AMAPK1NPC1
SCHEMBL9183872 0.84 HSPB1 (0.79) HSPB1MEN1KMT2AMAPK1NPC1
SCHEMBL2011179 0.84 HSPB1 (0.79) HSPB1MEN1KMT2AMAPK1NPC1
SCHEMBL11689190 0.84 HSPB1 (0.79) HSPB1MEN1KMT2AMAPK1NPC1
4,4'-Oxybis(Nitrobenzene) SCHEMBL134332 0.84 HSPB1 (0.79) HSPB1MEN1KMT2AMAPK1NPC1
SCHEMBL9504990 0.84 TSHR (0.61) MEN1KMT2AMAPTRAB9AALDH1A1
SCHEMBL10627979 0.84 ALDH1A1 (0.61) HSPB1MEN1KMT2ARAB9AALDH1A1
SCHEMBL10569272 0.82 POLB (0.63) MEN1KMT2AMAPTALDH1A1IDO1
Methyl Alcohol SCHEMBL28472878 0.82 TSHR (0.57) MAPK1ALDH1A1IDO1LOXL2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6953789-B2 Thiol compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2005-10-11 US disclosed
US-20040157894-A1 Thiol compounds, their production and use TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-08-12 US disclosed
US-6699881-B2 MATRIX METALLOPROTEASE INHIBITORS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2004-03-02 US disclosed
US-20030078253-A1 Thiol compounds, their production and use TAKEDA PHARMACEUTICAL COMPANY, LIMITED (JP) 2003-04-24 US disclosed
US-6420415-B1 Thiol compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2002-07-16 US disclosed
EP-1132379-A1 NOVEL THIOL DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND UTILIZATION THEREOF Takeda Chemical Industries, Ltd. (JP) 2001-09-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030078253-A1 Thiol compounds, their production and use TST, QSOX1, SULT1E1 HSPB1 791/4885MEN1 3957/4885KMT2A 1898/4885
US-20040157894-A1 Thiol compounds, their production and use TST, SULT1E1, QSOX1 HSPB1 807/4885MEN1 3906/4885KMT2A 1850/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.